A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial)
- Resource Type
- Article
- Source
- In
Journal of Investigative Dermatology January 2020 140(1):85-93 - Subject
- Language
- ISSN
- 0022-202X